Ning Y, Zheng M, Zhang Y, Jiao Y, Wang J, Zhang S
Cancer Cell Int. 2024; 24(1):339.
PMID: 39402585
PMC: 11475559.
DOI: 10.1186/s12935-024-03519-7.
Tang J, Feng Y, Zhang B, Wu Y, Guo Z, Liang S
BMC Genomics. 2021; 22(1):491.
PMID: 34193047
PMC: 8246668.
DOI: 10.1186/s12864-021-07820-x.
Ruggiero C, Lalli E
Cancer Metastasis Rev. 2021; 40(1):89-140.
PMID: 33471283
DOI: 10.1007/s10555-020-09936-0.
Singh D, Bharti A, Biswas D, Tewari M, Kar A, Ansari M
J Gastrointest Cancer. 2021; 53(2):237-244.
PMID: 33417200
DOI: 10.1007/s12029-020-00560-3.
Piao X, Jeong P, Yan C, Kim Y, Byun Y, Xu Y
Oncol Lett. 2020; 19(1):476-486.
PMID: 31897161
PMC: 6924059.
DOI: 10.3892/ol.2019.11123.
Functions of Rhotekin, an Effector of Rho GTPase, and Its Binding Partners in Mammals.
Ito H, Morishita R, Nagata K
Int J Mol Sci. 2018; 19(7).
PMID: 30037057
PMC: 6073136.
DOI: 10.3390/ijms19072121.
Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
Chen X, Zhang S, Wang Z, Wang F, Cao X, Wu Q
J Exp Clin Cancer Res. 2018; 37(1):128.
PMID: 29954442
PMC: 6025706.
DOI: 10.1186/s13046-018-0787-2.
High expression of Nectin-4 is associated with unfavorable prognosis in gastric cancer.
Zhang Y, Zhang J, Shen Q, Yin W, Huang H, Liu Y
Oncol Lett. 2018; 15(6):8789-8795.
PMID: 29805618
PMC: 5950544.
DOI: 10.3892/ol.2018.8365.
Over-expression of suppressed cell proliferation, migration, invasion, and tumor growth in gastric cancer by restraining over-activation of MAPK signaling pathways.
Li Y, Ji S, Fu L, Jiang T, Wu D, Meng F
Onco Targets Ther. 2018; 11:279-290.
PMID: 29386906
PMC: 5767098.
DOI: 10.2147/OTT.S130255.
Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.
Ferraiuolo M, Verduci L, Blandino G, Strano S
Int J Mol Sci. 2017; 18(5).
PMID: 28467351
PMC: 5454874.
DOI: 10.3390/ijms18050961.
FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.
Kubo E, Shibata S, Shibata T, Kiyokawa E, Sasaki H, Singh D
J Cell Mol Med. 2016; 21(5):916-928.
PMID: 27976512
PMC: 5387175.
DOI: 10.1111/jcmm.13030.
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
de Miguel F, Pajares M, Martinez-Terroba E, Ajona D, Morales X, Sharma R
Mol Oncol. 2016; 10(9):1437-1449.
PMID: 27555542
PMC: 5423218.
DOI: 10.1016/j.molonc.2016.08.001.
The Role of Integrins αMβ2 (Mac-1, CD11b/CD18) and αDβ2 (CD11d/CD18) in Macrophage Fusion.
Podolnikova N, Kushchayeva Y, Wu Y, Faust J, Ugarova T
Am J Pathol. 2016; 186(8):2105-2116.
PMID: 27315778
PMC: 4973655.
DOI: 10.1016/j.ajpath.2016.04.001.
Starvation after Cobalt-60 γ-Ray Radiation Enhances Metastasis in U251 Glioma Cells by Regulating the Transcription Factor SP1.
Zhao T, Wang H, Ma H, Wang H, Chen B, Deng Y
Int J Mol Sci. 2016; 17(4):386.
PMID: 27058528
PMC: 4848883.
DOI: 10.3390/ijms17040386.
Rho GTPases: Novel Players in the Regulation of the DNA Damage Response?.
Fritz G, Henninger C
Biomolecules. 2015; 5(4):2417-34.
PMID: 26437439
PMC: 4693241.
DOI: 10.3390/biom5042417.
SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction.
Pasquier J, Abu-Kaoud N, Abdesselem H, Madani A, Hoarau-Vechot J, Al Thawadi H
BMC Cancer. 2015; 15:569.
PMID: 26231656
PMC: 4522077.
DOI: 10.1186/s12885-015-1556-7.
Approaches of targeting Rho GTPases in cancer drug discovery.
Lin Y, Zheng Y
Expert Opin Drug Discov. 2015; 10(9):991-1010.
PMID: 26087073
PMC: 4824952.
DOI: 10.1517/17460441.2015.1058775.
Swiprosin-1 stimulates cancer invasion and metastasis by increasing the Rho family of GTPase signaling.
Huh Y, Oh S, Yeo Y, Chae I, Kim S, Lee J
Oncotarget. 2015; 6(15):13060-71.
PMID: 26079945
PMC: 4536999.
DOI: 10.18632/oncotarget.3637.
The Correlation Between RhoA Expression and Clinicopathological Characteristics in Gastric Cancer Patients After Curative Surgery.
Huang K, Lan Y, Chen M, Chao Y, Lo S, Li A
World J Surg. 2015; 39(9):2289-99.
PMID: 26013205
DOI: 10.1007/s00268-015-3095-4.
Janus-faces of NME-oncoprotein interactions.
Vlatkovic N, Chang S, Boyd M
Naunyn Schmiedebergs Arch Pharmacol. 2014; 388(2):175-87.
PMID: 25366701
DOI: 10.1007/s00210-014-1062-5.